PMCB

PMCB

USD

PharmaCyte Biotech Inc. Common Stock

$0.890-0.010 (-1.111%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$0.900

Hoch

$0.917

Tief

$0.880

Volumen

0.00M

Unternehmensfundamentaldaten

Marktkapitalisierung

6.0M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.10M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.8Aktuell $0.890Hoch $1.94

Ähnliche Nachrichten

BusinessWire

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure Technologies PharmaCyte Biotech, Inc. (NASDAQ:PMCB)

Mehr anzeigen
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
BusinessWire

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had approximately $15.5 million in

Mehr anzeigen
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
BusinessWire

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announced today that it has entered into a securities purchase agreement for a $7.0 million financing with existing investors involving the sale of

Mehr anzeigen
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors